TY - JOUR
T1 - Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer
AU - Wirtenberger, Michael
AU - Frank, Bernd
AU - Hemminki, Kari
AU - Klaes, Rüdiger
AU - Schmutzler, Rita K.
AU - Wappenschmidt, Barbara
AU - Meindl, Alfons
AU - Kiechle, Marion
AU - Arnold, Norbert
AU - Weber, Bernhard H.F.
AU - Niederacher, Dieter
AU - Bartram, Claus R.
AU - Burwinkel, Barbara
N1 - Funding Information:
The authors are grateful to Bowang Chen and Justo L. Bermejo for statistical analyses as well as Dagmar Beisse and Julia Schmutzhard for performing TaqMan assays. The German breast cancer samples were collected within a project funded by the Deutsche Krebshilfe, supported by the Center of Molecular Medicine, Cologne (CMMC) and coordinated by Rita K.Schmutzler. This study was supported by the EU, LSHC-CT-2004-503465.
PY - 2006/8
Y1 - 2006/8
N2 - Mutations of the human RecQ helicase genes WRN and BLM lead to rare autosomal recessive disorders, Werner and Bloom syndromes, which are associated with premature ageing and cancer predisposition. We tested the hypothesis whether three polymorphic, non-conservative amino acid exchanges in WRN and BLM act as low-penetrance familial breast cancer risk factors. Moreover, we examined the putative impact of p53 Msp I 1798G>A, which is completely linked to p53PIN3, a 16 bp insertion/ duplication that has been associated with reduced p53 expression, on familial breast cancer risk. Genotyping analyses, performed on 816 BRCA1/ 2 mutation-negative German familial breast cancer patients and 1012 German controls, revealed a significant association of the WRN Cys 1367 Arg polymorphism with familial breast cancer (OR = 1.28, 95% CI 1.06-1.54) and high-risk familial breast cancer (OR = 1.32, 95% CI 1.06-1.65). The analysis of p53 Msp I 1798G>A, which is completely linked to p53PIN3, showed a significantly increased familial breast cancer risk for carriers of the 16 bp insertion/duplication, following a recessive mode (OR = 2.15, 95% CI = 1.12-4.11). WRN Cys 1367 Arg, located in the C-terminus, the binding site of p53, is predicted to be damaging. The joint effect of WRN Cys 1367 Arg and p53 Msp I resulted in an increased breast cancer risk compared to the single polymorphisms (OR = 3.39, 95% CI 1.19-9.71). In conclusion, our study indicates the importance of inherited variants in the WRN and p53 genes for familial breast cancer susceptibility.
AB - Mutations of the human RecQ helicase genes WRN and BLM lead to rare autosomal recessive disorders, Werner and Bloom syndromes, which are associated with premature ageing and cancer predisposition. We tested the hypothesis whether three polymorphic, non-conservative amino acid exchanges in WRN and BLM act as low-penetrance familial breast cancer risk factors. Moreover, we examined the putative impact of p53 Msp I 1798G>A, which is completely linked to p53PIN3, a 16 bp insertion/ duplication that has been associated with reduced p53 expression, on familial breast cancer risk. Genotyping analyses, performed on 816 BRCA1/ 2 mutation-negative German familial breast cancer patients and 1012 German controls, revealed a significant association of the WRN Cys 1367 Arg polymorphism with familial breast cancer (OR = 1.28, 95% CI 1.06-1.54) and high-risk familial breast cancer (OR = 1.32, 95% CI 1.06-1.65). The analysis of p53 Msp I 1798G>A, which is completely linked to p53PIN3, showed a significantly increased familial breast cancer risk for carriers of the 16 bp insertion/duplication, following a recessive mode (OR = 2.15, 95% CI = 1.12-4.11). WRN Cys 1367 Arg, located in the C-terminus, the binding site of p53, is predicted to be damaging. The joint effect of WRN Cys 1367 Arg and p53 Msp I resulted in an increased breast cancer risk compared to the single polymorphisms (OR = 3.39, 95% CI 1.19-9.71). In conclusion, our study indicates the importance of inherited variants in the WRN and p53 genes for familial breast cancer susceptibility.
UR - http://www.scopus.com/inward/record.url?scp=33747894213&partnerID=8YFLogxK
U2 - 10.1093/carcin/bgi374
DO - 10.1093/carcin/bgi374
M3 - Article
C2 - 16501249
AN - SCOPUS:33747894213
SN - 0143-3334
VL - 27
SP - 1655
EP - 1660
JO - Carcinogenesis
JF - Carcinogenesis
IS - 8
ER -